Am J Psychiatry 159:1848-1854, November 2002
© 2002 American Psychiatric Association
Are There Differences Between Women’s and Men’s Antidepressant Responses?
Frederic M. Quitkin, M.D.,
Jonathan W. Stewart, M.D.,
Patrick J. McGrath, M.D.,
Bonnie P. Taylor, M.A.,
Mayra S. Tisminetzky, M.D.,
Eva Petkova, Ph.D.,
Ying Chen, M.D.,
Guoguang Ma, Ph.D., and
Donald F. Klein, M.D.
OBJECTIVE: The study examined a large data set to determine whether patients’ sex affected the outcome of antidepressant treatment. METHOD: Data for 1,746 patients aged 18–65 years who had been treated with tricyclic antidepressants, monoamine oxidase inhibitors (MAOIs), fluoxetine, or placebo were examined in a retrospective analysis to determine whether men and women differed in their responses to antidepressants. To examine the effect of menopausal status in the absence of data on individual patients’ menopausal status, results for female patients younger or older than age 50, 52, 54, and 56 were compared. RESULTS: Men and women both younger and older than age 50 had equivalent response rates to tricyclics and fluoxetine. Women had a statistically superior response to MAOIs. Placebo response was equivalent across all groups. CONCLUSIONS: Neither sex nor menopausal status may be relevant in antidepressant treatment of adult depressed patients up to 65 years of age. Although women had a statistically superior response to MAOIs, this difference may not be clinically relevant.
This article has been cited by other articles:
|
|
|
|
 
M. O. Edelen, M. A. Burnam, K. E. Watkins, J. J. Escarce, H. Huskamp, H. H. Goldman, and G. Rachelefsky
Obtaining Utility Estimates of the Health Value of Commonly Prescribed Treatments for Asthma and Depression
Med Decis Making,
September 1, 2008;
28(5):
732 - 750.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. J. Rush, S. R. Wisniewski, D. Warden, J. F. Luther, L. L. Davis, M. Fava, A. A. Nierenberg, and M. H. Trivedi
Selecting Among Second-Step Antidepressant Medication Monotherapies: Predictive Value of Clinical, Demographic, or First-Step Treatment Features
Arch Gen Psychiatry,
August 1, 2008;
65(8):
870 - 880.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. McGrath, J. W. Stewart, F. M. Quitkin, Y. Chen, J. E. Alpert, A. A. Nierenberg, M. Fava, J. Cheng, and E. Petkova
Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression
Am J Psychiatry,
September 1, 2006;
163(9):
1542 - 1548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. K. Burt, M. M. Wohlreich, C. H. Mallinckrodt, M. J. Detke, J. G. Watkin, and D. E. Stewart
Duloxetine for the Treatment of Major Depressive Disorder in Women Ages 40 to 55 Years
Psychosomatics,
August 1, 2005;
46(4):
345 - 354.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Fochtmann and A. J. Gelenberg
Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition
Focus,
January 1, 2005;
3(1):
34 - 42.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Khan, R. L. Kolts, M. E. Thase, K. R. R. Krishnan, and W. Brown
Research Design Features and Patient Characteristics Associated With the Outcome of Antidepressant Clinical Trials
Am J Psychiatry,
November 1, 2004;
161(11):
2045 - 2049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Wohlfarth, J. G. Storosum, A. J.A. Elferink, B. J. van Zwieten, A. Fouwels, and W. van den Brink
Response to Tricyclic Antidepressants: Independent of Gender?
Am J Psychiatry,
February 1, 2004;
161(2):
370 - 372.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Sex Differences in Antidepressant Effectiveness?
Journal Watch Psychiatry,
January 23, 2003;
2003(123):
8 - 8.
[Full Text]
|
|
|
|
|
|
|
Sex Differences in Antidepressant Effectiveness?
Journal Watch Women's Health,
December 4, 2002;
2002(1204):
10 - 10.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
